You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 97 No. 9, September 1979 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (18)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Experimental Vitreous Fibroplasia Following Perforating Ocular Injuries

A. Raymond Pilkerton, MD; Narsing A. Rao, MD; George E. Marak, MD; Stephen C. Woodward, MD

Arch Ophthalmol. 1979;97(9):1707-1709.


Abstract

• Biochemical data and histopathologic observations were made on an experimental model of vitreous fibroplasia in the rabbit eye, with comparisons between the change in vitreous collagen concentration and histologic characteristics 7, 14, and 30 days after injury. Prior to two weeks after injury there is a relatively small amount of new vitreous collagen formed, associated with an inflammatory and vascular reaction. At four weeks there is a marked increase in new vitreous collagen and dense fibrous sheets are noted. Vitreous hemorrhage accelerates collagen formation, and methylprednisolone sodium succinate does not decrease vitreous fibrosis. Our results suggest that the optimum time for vitrectomy, under the conditions of this experiment, is two weeks after primary repair. The efficacy of steroids in retarding vitreous fibroplasia is not supported.



Author Affiliations

From the Departments of Ophthalmology (Drs Pilkerton, Rao, and Marak) and Pathology (Dr Rao), Georgetown University Medical Center, Veterans Administration Hospital, and Hunter Memorial Laboratory (Dr Woodward), Washington, DC.


Footnotes

Accepted for publication Dec 29, 1978.

Presented in part at the Walter Reed Hospital Biennial Ophthalmology Course and Annual Meeting, Washington, DC, April 12, 1978.

Reprint requests to Surgical Research (151-C), Room GD-214, Veterans Administration Hospital, 50 Irving St NW, Washington, DC 20422 (Dr Pilkerton).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Perforating (Through-and-Through) Injuries of the Globe: Surgical Results With Vitrectomy
Martin et al.
Arch Ophthalmol 1991;109:951-956.
ABSTRACT  

Intraocular Cannula for Continuous, Chronic Drug Delivery: Histopathologic Observations and Function
Miki et al.
Arch Ophthalmol 1985;103:712-717.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.